Acyclovir (Aciclovir)
Antiviral medication for herpes simplex, chickenpox and shingles
Quick Facts about Acyclovir
Key Takeaways about Acyclovir
- First-line antiviral: Acyclovir is the gold-standard treatment for herpes simplex and varicella-zoster infections, listed on the WHO Essential Medicines List
- Start treatment early: Treatment is most effective when started within 72 hours of symptom onset, ideally at the first sign of tingling or prodromal symptoms
- Stay hydrated: Adequate fluid intake is essential during treatment to prevent crystal formation in the kidneys, especially in elderly patients and those on high doses
- Dose adjustment for kidneys: Patients with impaired kidney function require dose reduction or extended dosing intervals to avoid accumulation
- Does not cure herpes: Acyclovir suppresses viral replication but does not eliminate the latent virus; recurrences may occur after treatment stops
What Is Acyclovir and What Is It Used For?
Acyclovir is a synthetic nucleoside analogue antiviral medication that selectively inhibits herpes virus replication. It is used to treat and prevent infections caused by herpes simplex virus types 1 and 2 (cold sores and genital herpes), varicella-zoster virus (chickenpox and shingles), and to prevent viral reactivation in immunocompromised patients.
Acyclovir belongs to a group of medicines known as nucleoside analogue antivirals. It was first synthesised in the late 1970s by Gertrude Elion and George Hitchings at Burroughs Wellcome (now GlaxoSmithKline), a discovery that contributed to their Nobel Prize in Physiology or Medicine in 1988. Since its introduction, acyclovir has become one of the most widely used antiviral agents worldwide and remains on the World Health Organization's Model List of Essential Medicines.
The drug works by a unique mechanism: once inside a virus-infected cell, acyclovir is phosphorylated by a viral enzyme called thymidine kinase (TK). This first phosphorylation step is highly specific to virus-infected cells, meaning the drug has minimal effect on uninfected host cells. The monophosphate form is then converted by cellular kinases to acyclovir triphosphate, which acts as a competitive inhibitor of viral DNA polymerase and causes premature chain termination of the viral DNA strand. This selective activation is what gives acyclovir its favourable safety profile compared to earlier antiviral agents.
Acyclovir is effective against the following viral infections:
- Herpes simplex virus type 1 (HSV-1): Causes cold sores (herpes labialis), herpetic keratitis (eye infections), and herpes encephalitis
- Herpes simplex virus type 2 (HSV-2): The primary cause of genital herpes, though HSV-1 can also cause genital infections
- Varicella-zoster virus (VZV): Causes chickenpox (varicella) on primary infection and shingles (herpes zoster) on reactivation
- Epstein-Barr virus (EBV): Some activity, though not a first-line treatment
- Cytomegalovirus (CMV): Used prophylactically in immunocompromised patients, though ganciclovir is more potent for active CMV disease
Acyclovir is available in several dosage forms to suit different clinical needs: oral tablets (200 mg, 400 mg, and 800 mg), a topical cream (5%) for localised skin lesions, and an intravenous formulation (25 mg/ml powder for solution for infusion) for severe or life-threatening infections requiring rapid systemic drug levels. The oral bioavailability of acyclovir is relatively low (approximately 15–30%), which is why the prodrug valacyclovir was later developed to improve oral absorption.
Acyclovir is listed on the WHO Model List of Essential Medicines (2023), recognising it as one of the most important medications needed in a basic health system. This designation reflects its proven efficacy, safety, and cost-effectiveness in treating herpes virus infections globally.
What Should You Know Before Taking Acyclovir?
Before starting acyclovir, inform your doctor if you have kidney problems, are over 65 years old, or are taking other medications. Ensure adequate hydration throughout treatment. Acyclovir should not be used if you are allergic to acyclovir or valacyclovir.
While acyclovir is generally well tolerated, there are important considerations before starting treatment. Your doctor needs to assess whether this medication is appropriate for you and may need to adjust the dose based on your individual circumstances. Being open about your medical history and current medications helps ensure safe and effective treatment.
Contraindications
You must not take acyclovir if you have a known allergy (hypersensitivity) to acyclovir, valacyclovir, or any of the other ingredients in the formulation. Valacyclovir is a prodrug that is converted to acyclovir in the body, so cross-reactivity between these two medications is expected. Allergic reactions can range from mild skin rashes to severe anaphylactic reactions, though the latter are very rare.
Warnings and Precautions
Talk to your doctor or pharmacist before taking acyclovir if any of the following apply to you:
- Kidney (renal) impairment: Acyclovir is primarily excreted by the kidneys. In patients with reduced kidney function, the drug can accumulate to potentially toxic levels. Dose adjustment is essential, and your doctor will likely check your kidney function (creatinine clearance) before and during treatment.
- Age over 65 years: Elderly patients are more likely to have age-related decline in kidney function, even if their serum creatinine appears normal. Dose reduction and careful monitoring are recommended.
- Dehydration risk: Acyclovir crystals can precipitate in the renal tubules if fluid intake is insufficient, potentially leading to acute kidney injury. This risk is particularly elevated in elderly patients, those receiving high intravenous doses, and patients with pre-existing renal compromise. Drinking plenty of water during treatment is strongly recommended.
- Immunocompromised state: While acyclovir is frequently used in immunocompromised patients, prolonged or repeated courses can lead to the development of acyclovir-resistant herpes strains. This is more common in patients with HIV/AIDS or those receiving chemotherapy.
Pregnancy and Breastfeeding
If you are pregnant, breastfeeding, think you may be pregnant, or are planning to have a baby, seek advice from your doctor before taking acyclovir. While animal reproductive studies have not shown direct harmful effects, there are no adequate and well-controlled studies in pregnant women. Acyclovir should only be used during pregnancy when the potential benefit outweighs the potential risk to the foetus.
Post-marketing surveillance registries (such as the Acyclovir in Pregnancy Registry, which monitored outcomes of over 1,000 pregnancies) have not shown an increased risk of birth defects compared to the general population. However, the data are insufficient to draw definitive conclusions. Many international guidelines (including those from the CDC and RCOG) do support the use of acyclovir in late pregnancy to prevent neonatal herpes in women with active genital herpes.
Acyclovir is excreted in breast milk at concentrations approximately 0.6 to 4.1 times the corresponding plasma levels. However, the dose an infant would receive through breast milk is estimated to be less than 1% of a typical paediatric dose, which is generally considered clinically insignificant. The decision to continue or discontinue breastfeeding should be made in consultation with your doctor, weighing the benefits of breastfeeding against the potential exposure.
Driving and Using Machines
The effects of acyclovir on the ability to drive and use machines have not been formally studied. However, some side effects such as dizziness, drowsiness, and confusion may impair your ability to concentrate and react. Avoid driving or operating machinery until you know how acyclovir affects you. You are personally responsible for assessing whether you are fit to drive or perform tasks requiring alertness.
Acyclovir oral tablets contain less than 1 mmol (23 mg) sodium per tablet, making them essentially sodium-free. This is relevant for patients on sodium-restricted diets.
How Does Acyclovir Interact with Other Drugs?
Acyclovir has relatively few significant drug interactions. The most important interactions involve probenecid (which increases acyclovir levels), cimetidine (which may increase acyclovir exposure), and mycophenolate mofetil (used in transplant medicine). Always tell your doctor about all medications you are taking.
Compared to many other medications, acyclovir has a relatively clean drug interaction profile. This is partly because it is not significantly metabolised by the cytochrome P450 enzyme system, which is responsible for many drug-drug interactions. However, there are some clinically relevant interactions that your healthcare provider should be aware of.
The following table summarises the most important known drug interactions with acyclovir:
| Interacting Drug | Effect | Clinical Significance | Recommendation |
|---|---|---|---|
| Probenecid | Reduces renal excretion of acyclovir, increasing plasma levels by up to 40% | Major | Dose adjustment may be required; monitor for acyclovir toxicity |
| Cimetidine | Inhibits tubular secretion, may increase acyclovir AUC | Moderate | Monitor kidney function; consider alternative H2 blocker |
| Mycophenolate mofetil | Mutual competition for renal tubular secretion; may increase levels of both drugs | Moderate | Monitor renal function and adverse effects closely |
| Nephrotoxic drugs | Additive nephrotoxicity risk (e.g. aminoglycosides, ciclosporin, tacrolimus) | Major | Monitor renal function frequently; ensure adequate hydration |
| Lithium | Potential increase in lithium levels due to reduced renal clearance | Moderate | Monitor lithium levels during co-administration |
| Theophylline | Potential increase in theophylline levels | Minor | Monitor theophylline levels if symptoms of toxicity appear |
Important Considerations for Drug Interactions
Because acyclovir is primarily eliminated by the kidneys through both glomerular filtration and active tubular secretion, any drug that affects these processes can potentially alter acyclovir's pharmacokinetics. This is particularly important when treating patients who are already receiving multiple medications, such as transplant recipients or patients with HIV/AIDS.
It is also worth noting that while acyclovir itself has few interactions, patients receiving acyclovir often have conditions that require other treatments. For example, patients with herpes zoster (shingles) frequently take pain medications including opioids and gabapentinoids, and there is no clinically significant interaction between acyclovir and these commonly co-prescribed analgesics.
What Is the Correct Dosage of Acyclovir?
Acyclovir dosage varies significantly depending on the condition being treated. For oral herpes simplex treatment, the typical adult dose is 200 mg five times daily for 5 days. For shingles, the dose is 800 mg five times daily for 7 days. Always follow your doctor's instructions, as dose adjustments are required for kidney impairment and in elderly patients.
The dosage of acyclovir depends on several factors: the type of infection being treated, the severity of the condition, the patient's age, body weight (in children), and kidney function. Always take acyclovir exactly as prescribed by your doctor or pharmacist. Do not change your dose without consulting your healthcare provider.
Adult Dosage
| Indication | Dose | Frequency | Duration |
|---|---|---|---|
| HSV treatment (cold sores, genital herpes) | 200 mg | 5 times daily (every 4 hours, omitting night dose) | 5 days (may extend for severe infections) |
| HSV suppression (prophylaxis) | 200 mg 4 times daily or 400 mg twice daily | Every 6 hours or every 12 hours | Long-term (reassess every 6–12 months) |
| Chickenpox (varicella) | 800 mg | 5 times daily (every 4 hours) | 7 days |
| Shingles (herpes zoster) | 800 mg | 5 times daily (every 4 hours) | 7 days |
For the treatment of herpes simplex infections, it is crucial to start treatment as early as possible, ideally at the first sign of prodromal symptoms such as tingling, itching, or burning. Early treatment can significantly reduce the duration and severity of an outbreak. In patients with frequently recurrent genital herpes (6 or more episodes per year), long-term suppressive therapy with acyclovir 400 mg twice daily may be recommended.
Children's Dosage
| Indication | Age Group | Dose | Frequency & Duration |
|---|---|---|---|
| HSV treatment | 3 months–2 years | 100 mg | 5 times daily for 5 days |
| HSV treatment | Over 2 years | 200 mg | 5 times daily for 5 days |
| HSV prophylaxis (immunocompromised) | 3 months–2 years | 100 mg | 4 times daily (every 6 hours) |
| HSV prophylaxis (immunocompromised) | Over 2 years | 200 mg | 4 times daily (every 6 hours) |
| Chickenpox | Under 2 years | 200 mg | 4 times daily for 5 days |
| Chickenpox | 2–6 years | 400 mg | 4 times daily for 5 days |
| Chickenpox | Over 6 years | 800 mg | 4 times daily for 5 days |
For children with chickenpox, the dose may be calculated more precisely as 20 mg per kg of body weight (up to a maximum of 800 mg per individual dose) given four times daily. A liquid formulation (oral suspension) of acyclovir is available and may be more suitable for young children who have difficulty swallowing tablets.
Elderly Patients and Renal Impairment
In elderly patients and in patients with impaired kidney function, the dose of acyclovir must be reduced. The kidney's ability to clear acyclovir decreases with age, and drug accumulation can lead to neurological side effects including confusion, tremors, and in severe cases, encephalopathy. Your doctor will calculate the appropriate dose based on your creatinine clearance (a measure of kidney function).
It is particularly important for elderly patients to maintain adequate fluid intake during acyclovir therapy. Dehydration increases the risk of acyclovir crystalluria (crystal deposits in the kidneys), which can cause acute kidney injury. Aim to drink at least 1.5 to 2 litres of water daily, unless your doctor has advised fluid restriction for another medical reason.
Missed Dose
If you forget to take a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a forgotten one. If you miss doses frequently, consider setting reminders or alarms to help you stay on schedule.
Overdose
If you or someone else has taken too much acyclovir, contact a poison control centre or seek emergency medical attention immediately. Symptoms of overdose may include nausea, vomiting, confusion, hallucinations, agitation, seizures, and kidney injury. Acyclovir is removed by haemodialysis, which may be considered in cases of severe overdose, particularly in patients with kidney failure.
Always drink plenty of water while taking acyclovir tablets, especially if you are elderly or taking high doses. Inadequate hydration can lead to kidney damage due to acyclovir crystal deposition in the renal tubules. Contact your doctor immediately if you experience reduced urine output or lower back pain during treatment.
What Are the Side Effects of Acyclovir?
Like all medicines, acyclovir can cause side effects, though not everyone experiences them. The most common side effects include headache, dizziness, nausea, diarrhoea, and skin rash. Serious side effects such as severe allergic reactions, kidney problems, and neurological symptoms are rare. Stop taking acyclovir and seek immediate medical attention if you develop signs of a severe allergic reaction.
Acyclovir is generally well tolerated, and serious adverse effects are uncommon at recommended oral doses. The risk of side effects increases with higher doses, intravenous administration, impaired kidney function, and dehydration. Below is a comprehensive overview of reported side effects organised by frequency, as defined by internationally standardised terminology.
Signs of a severe allergic reaction (anaphylaxis or angioedema), which may include sudden onset of hives, swelling of the face, lips, tongue, or other body parts, difficulty breathing or wheezing, or collapse. These reactions are rare (affecting fewer than 1 in 1,000 people) but require emergency treatment.
Common Side Effects
- Headache
- Dizziness
- Nausea
- Abdominal pain
- Diarrhoea
- Itching (pruritus)
- Skin rash (including photosensitivity)
- Fatigue
- Fever
Uncommon Side Effects
- Urticaria (itchy hives)
- Hair loss (alopecia) – usually reversible
Rare Side Effects
- Elevated blood urea nitrogen and creatinine (indicating kidney stress)
- Elevated liver enzymes (bilirubin, transaminases)
- Dyspnoea (difficulty breathing)
- Anaphylaxis / angioedema (severe allergic reaction)
Very Rare Side Effects
- Anaemia (reduced red blood cells)
- Leucopenia (reduced white blood cells)
- Thrombocytopenia (reduced platelets)
- Agitation, confusion, psychosis
- Tremor, ataxia (unsteady gait)
- Dysarthria (speech difficulties)
- Hallucinations
- Seizures (convulsions)
- Encephalopathy (brain dysfunction), somnolence, coma
- Hepatitis, jaundice
- Acute kidney injury (renal pain, reduced urine output)
Neurological Side Effects
Neurological side effects of acyclovir deserve special mention because, while rare, they can be serious. These effects are more likely to occur in elderly patients, those with impaired kidney function, and patients receiving high intravenous doses. Symptoms may include confusion, agitation, tremors, hallucinations, seizures, and in severe cases, encephalopathy or coma. These neurological effects are generally reversible upon discontinuation of acyclovir and correction of any underlying factors such as dehydration or renal impairment.
The mechanism behind acyclovir-induced neurotoxicity is thought to involve accumulation of the drug and its metabolite 9-carboxymethoxymethylguanine (CMMG) in patients with reduced renal clearance. Monitoring kidney function and maintaining adequate hydration are key preventive measures.
Kidney-Related Side Effects
Acyclovir-related nephrotoxicity primarily occurs through crystal precipitation in the renal tubules. Risk factors include rapid intravenous infusion, inadequate hydration, pre-existing renal disease, and concomitant use of other nephrotoxic drugs. When acyclovir is administered intravenously, it should be infused slowly over at least one hour to reduce the risk of renal crystal deposition. Oral acyclovir is much less likely to cause nephrotoxicity, provided adequate fluid intake is maintained.
Reporting Side Effects
If you experience any side effects, including those not listed here, talk to your doctor or pharmacist. You can also report side effects to your national medicines regulatory authority. Reporting helps improve knowledge about the safety of medications.
How Should You Store Acyclovir?
Store acyclovir tablets below 30°C (86°F) in a dry place. Keep out of sight and reach of children. Do not use after the expiry date printed on the packaging. Return unused medicines to your pharmacy for safe disposal.
Proper storage of medications is essential to maintain their effectiveness and safety. Acyclovir tablets should be stored at room temperature, not exceeding 30°C (86°F). Avoid storing them in bathrooms or near sinks where moisture levels are high, as humidity can degrade the tablets. Keep the blister packs in the original outer carton to protect from light exposure.
Always keep acyclovir and all medicines out of the sight and reach of children. The tablets should be stored in their original packaging until it is time to take them. Do not use acyclovir after the expiry date stated on the carton or blister pack – the expiry date refers to the last day of that month.
Do not dispose of medications via wastewater or household waste. Ask your pharmacist how to properly dispose of medicines you no longer use. These measures help protect the environment and prevent accidental exposure.
What Does Acyclovir Contain?
Each acyclovir tablet contains the active substance aciclovir (available in 200 mg, 400 mg, and 800 mg strengths). The inactive ingredients include microcrystalline cellulose, povidone, sodium starch glycolate, and magnesium stearate. The tablets are sodium-free.
Understanding what your medication contains is important, particularly if you have known allergies or intolerances to specific excipients (inactive ingredients). Below is a detailed breakdown of what acyclovir tablets contain.
Active Ingredient
The active substance is aciclovir (also spelled acyclovir in American English). Each tablet contains either 200 mg, 400 mg, or 800 mg of aciclovir, depending on the prescribed strength. Aciclovir is a white crystalline powder with the molecular formula C8H11N5O3 and a molecular weight of 225.21 g/mol.
Inactive Ingredients (Excipients)
- Microcrystalline cellulose: A commonly used tablet filler and binder derived from plant cellulose
- Povidone: A binding agent that helps hold the tablet together
- Sodium starch glycolate (type A): A disintegrant that helps the tablet break down in the stomach for proper absorption
- Magnesium stearate: A lubricant used in tablet manufacturing to prevent sticking to equipment
Tablet Descriptions
| Strength | Appearance | Size | Packaging |
|---|---|---|---|
| 200 mg | White, round, biconvex, marked "200" | 9 mm diameter | 25 tablets (aluminium/PVC blister) |
| 400 mg | White, round, biconvex | 11 mm diameter | 56 or 70 tablets (aluminium/PVC blister) |
| 800 mg | White, oblong, biconvex, break line on one side | 19.3 mm × 10.5 mm | 35 tablets (aluminium/PVC blister) |
The break line (score) on the 800 mg tablets is designed only to help with swallowing by allowing the tablet to be broken into two pieces. It is not intended for splitting the tablet into equal doses. Always take the dose prescribed by your doctor.
Frequently Asked Questions about Acyclovir
Acyclovir is an antiviral medication used to treat infections caused by herpes simplex virus (HSV), including cold sores (herpes labialis) and genital herpes, as well as varicella-zoster virus (VZV) infections such as chickenpox and shingles (herpes zoster). It can also be used as preventive therapy in immunocompromised patients to reduce the risk of herpes simplex, herpes zoster, and cytomegalovirus (CMV) infections. Acyclovir is available as tablets, cream, and intravenous infusion.
Acyclovir begins working within hours of the first dose by inhibiting viral DNA replication. However, noticeable symptom improvement typically occurs within 2 to 3 days of starting treatment. For best results, treatment should be started as early as possible after symptoms appear – ideally within 72 hours of the onset of a herpes outbreak or shingles rash. Starting treatment at the first sign of prodromal symptoms (tingling, itching, or burning) can shorten the duration and severity of an episode.
Acyclovir should only be used during pregnancy when the potential benefits outweigh the risks. While post-marketing registries monitoring over 1,000 pregnancies have not shown an increased risk of birth defects, there are no definitive controlled studies in pregnant women. Many clinical guidelines support the use of acyclovir in late pregnancy to prevent neonatal herpes in women with active genital herpes. Always consult your doctor before taking acyclovir if you are pregnant, planning to become pregnant, or breastfeeding.
The most common side effects of acyclovir (affecting up to 1 in 10 users) include headache, dizziness, nausea, abdominal pain, diarrhoea, itching, skin rash, fatigue, and fever. These side effects are generally mild and transient. Serious side effects such as severe allergic reactions (anaphylaxis), kidney problems, or neurological symptoms (confusion, seizures) are rare. If you experience any concerning symptoms, contact your doctor promptly.
No, acyclovir does not cure herpes. The herpes simplex virus establishes latent infection in nerve ganglia and remains dormant even after treatment. Acyclovir works by stopping the virus from replicating during active infection, which helps reduce the severity and duration of outbreaks. When taken as long-term suppressive therapy (daily use), it can significantly reduce the frequency of recurrent outbreaks and lower the risk of transmission to sexual partners. However, once the virus has established latency, it cannot be eliminated by currently available antiviral medications.
Acyclovir tablets should be stored at temperatures below 30°C (86°F) in a dry place, away from direct sunlight and moisture. Keep the medication in its original packaging and out of the reach of children. Do not use acyclovir after the expiry date printed on the packaging. Dispose of unused medicines by returning them to your pharmacy – do not flush them down the toilet or put them in household rubbish.
References
All medical information in this article is based on peer-reviewed research, international clinical guidelines, and authoritative pharmaceutical references. The following sources were used:
- World Health Organization (WHO). Model List of Essential Medicines – 23rd list (2023). Geneva: WHO; 2023.
- European Medicines Agency (EMA). Aciclovir – Summary of Product Characteristics. EMA; 2024.
- U.S. Food and Drug Administration (FDA). Zovirax (Acyclovir) – Prescribing Information. FDA; 2023.
- British National Formulary (BNF). Aciclovir. NICE/BNF; 2025.
- Elion GB. The biochemistry and mechanism of action of acyclovir. J Antimicrob Chemother. 1983;12 Suppl B:9-17. doi:10.1093/jac/12.suppl_B.9
- Gnann JW Jr, Whitley RJ. Herpes Zoster. N Engl J Med. 2002;347(5):340-346. doi:10.1056/NEJMcp013211
- Kimberlin DW, Whitley RJ. Antiviral therapy of HSV-1 and -2. In: Arvin A, et al., eds. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Cambridge: Cambridge University Press; 2007.
- Stone KM, Reiff-Eldridge R, White AD, et al. Pregnancy outcomes following systemic prenatal acyclovir exposure: Conclusions from the international acyclovir pregnancy registry, 1984–1999. Birth Defects Res A Clin Mol Teratol. 2004;70(4):201-207.
- Izzedine H, Launay-Vacher V, Deray G. Antiviral drug-induced nephrotoxicity. Am J Kidney Dis. 2005;45(5):804-817. doi:10.1053/j.ajkd.2005.02.010
- Drugs.com. Acyclovir – Drug Information. Updated 2025.
Editorial Team
This article was written and medically reviewed by the iMedic Medical Editorial Team, comprising licensed physicians specialising in clinical pharmacology, infectious disease, and dermatology.
iMedic Medical Editorial Team
Specialists in Clinical Pharmacology
iMedic Medical Review Board
Independent medical expert panel
Level 1A Evidence
GRADE Framework Applied
WHO, EMA, FDA, BNF
No commercial funding